-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the heart blood vessels published a research article on the disease areas authoritative journal Stroke, researchers have attempted to clear the inflammation and coagulation biomarkers whether 2019 will help coronavirus disease ( COVID-19 ) associated with ischemic stroke to determine It is a new subtype of acute ischemic stroke (AIS)
Heart blood vessels COVID-19 Stroke
Researchers performed machine learning cluster analysis on common biomarkers of ischemic stroke patients admitted to the hospital due to severe acute respiratory syndrome coronavirus 2 infection to determine whether they are related to AIS
Infect
Based on the levels of C-reactive protein, D-dimer, lactate dehydrogenase, white blood cell count and partial thromboplastin time, cluster analysis combined 2908 unique patients into 4 unique biomarker phenotypes
D-dimer is the only biomarker independently related to the prevalence of AIS.
It can be seen that the COVID-19-related ischemic stroke may be related to the severity of the COVID-19 disease and the coagulation disorder with elevated D-dimer
The COVID-19-related ischemic stroke may be related to the severity of the COVID-19 disease and the coagulation disorder with elevated D-dimer
Original source:
Charles Esenwa.
